News

Filter

Current filters:

None

7950 to 7959 of 97840 results

Covagen collaborates with Mitsubishi Tanabe for the development of bispecific FynomAbs

17-10-2012

Privately-held Swiss firm Covagen has entered into a strategic research collaboration and license agreement…

CovagenFynomAbsMitsubishi TanabePharmaceutical

GlobalData Expert Insight: Fall from grace of Peregrine Pharma

17-10-2012

Last month, Peregrine Pharmaceuticals (Nasdaq: PPHM) announced the discovery of "major data discrepancies"…

bavituximabBiotechnologyCotaraFinancialOncologyPeregrine PharmaceuticalsResearch

Many UK patients still not receiving cost-effective NICE approved medicines

17-10-2012

A new report published yesterday by the UK's Health and Social Care Information Centre shows that NICE…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulation

Contract support and technical service providers expected to play growing role in drug development, says Tufts CSDD

17-10-2012

Drug sponsors and their contract service providers are using more sophisticated, integrated and coordinated…

BiotechnologyNorth AmericaPharmaceuticalResearch

Unanimous FDA advisory panel backing for NPS Pharma's Gattex

17-10-2012

The US Food and Drug Administration's Gastrointestinal Drugs Advisory Committee yesterday voted unanimously…

Gastro-intestinalsGattexNorth AmericaNPS PharmaceuticalsPharmaceuticalRegulationteduglutide

Johnson & Johnson beats expectations, despite 7% 3rd-qtr profit fall

17-10-2012

US health care giant Johnson & Johnson (NYSE: JNJ) yesterday revealed that its third-quarter 2012 profit…

FinancialJohnson & JohnsonPharmaceutical

Irish pharma agrees deal with govt for price cuts on medicines

17-10-2012

The Irish Pharmaceutical Healthcare Association (IPHA) this week announced a very significant new supply…

EuropePharmaceuticalPoliticsPricing

Novo Nordisk files hemophilia drug turoctocog in USA and EU

17-10-2012

Denmark's Novo Nordisk (NOV: N), the world's largest insulin maker, has submitted regulatory application…

EuropeNorth AmericaNovo NordiskPharmaceuticalRare diseasesRegulationturoctocog alfa

Theravance and Merck & Co enter cardiovascular disease accord

17-10-2012

Drug developer Theravance (Nasdaq: THRX) has signed a collaboration agreement with pharma giant Merck…

Cardio-vascularLicensingMerck & CoPharmaceuticalTheravance

7950 to 7959 of 97840 results

COMPANY SPOTLIGHT

Menarini

Back to top